Download Zicronapine - Analysis and Forecasts from 2014 to 2020 Brochure

Brochure
More information from http://www.researchandmarkets.com/reports/1934499/
Zicronapine - Analysis and Forecasts from 2014 to 2020
Description:
Zicronapine – Analysis and Forecasts from 2014 to 2020
Summary
GlobalData’s pharmaceuticals report, “Zicronapine – Analysis and Forecasts from 2014 to 2020” provides
Zicronapine sales estimates for US and EU5. In addition, it covers detailed clinical assessment of the drug,
factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast
period (2014-2020). The report also includes information on Schizophrenia market. This report is built using
data and information sourced from GlobalData’s proprietary databases, primary and secondary research
using Company’s corporate website, SEC filings, investor presentations and featured press releases, both
from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's
team of industry experts.
Scope
- Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
- Analysis and review of Zicronapine including sales data
- Qualitative and quantitative assessment of market space
- Analysis of the trends, drivers and restraints shaping and defining the markets
- In-depth analysis of Zicronapine including efficacy, safety, pricing and other details which influence its sales
potential
- Detailed sales forecast for 2014-2020 for Zicronapine in the US and EU5
Reasons to buy
- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of competition by understanding the changing competitive landscape
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales
potential
- Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
- Examine the historical sales performance of a drug in seven major markets
- Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
Contents:
1
1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Schizophrenia
2.2 Symptoms
2.3 Schizophrenia Market
2.4 Epidemiology
2.5 Etiology
2.5.1 Genetic Factors
2.5.2 Environmental Factors
2.5.3 Abnormal Brain Structure
2.6 GlobalData Report Guidance
3 Schizophrenia: Market Characterization
3.1 Schizophrenia Market
3.2 Schizophrenia Market Forecasts and CAGR
3.3 Drivers of Schizophrenia Therapeutics Market
3.3.1 Patent Expiry of Leading Marketed Drugs
3.3.2 Increasing Patient Pool
3.3.3 High Prescription Rates
3.3.4 Low Patient Compliance Rate
3.3.5 High Unmet Need
4 Classification of Schizophrenia
4.1 Age of Onset of Schizophrenia
4.1.1 Pediatric / Adolescent / Childhood Schizophrenia
4.1.2 Adult Schizophrenia
4.2 Associated Symptoms
4.2.1 Paranoid Schizophrenia
4.2.2 Disorganized Schizophrenia
4.2.3 Catatonic Schizophrenia
4.2.4 Residual Schizophrenia
4.2.5 Undifferentiated Disorder
5 Treatment for Schizophrenia
5.1 Crisis Resolution Teams (CRT)
5.2 Voluntary and Compulsory Detention
5.3 Antipsychotics
5.3.1 Typical Antipsychotics
5.3.2 Atypical Antipsychotics
5.3.3 Increased Mortality in Elderly Patients with Dementia-Related Psychosis
6 Zicronapine
6.1 Introduction
6.2 Mechanism of Action
6.3 Clinical Studies
6.4 Zicronapine Drug Development Status
6.5 Factors Affecting Sales of Zicronapine
6.5.1 Multi – Receptorial Profile
6.5.2 Affinity to Monaminergic Receptors
6.5.3 High Competition
6.5.4 Lack of Presence in Japan
6.5.5 Me too Drug
6.6 Intensity of Competition
6.7 Sales Forecasts
6.7.1 Target Patient Pool of Zicronapine
6.7.2 Dosing
6.7.3 Market Penetration
6.7.4 Annual Cost of Therapy
6.7.5 Sales Projections of Zicronapine
7 Schizophrenia Market: Appendix
7.1 Market Definitions
7.2 Abbreviations
7.3 Research Methodology
7.4 Drug Sales Estimates Model
7.5 Contact Us
7.6 Disclaimer
7.7 Sources
1.1 List of Tables
Table 1: Zicronapine, Drug Development Status, 2011
Table 2: Zicronapine, Annual Treatment Costs, 2014
Table 3: Zicronapine, Schizophrenia, Global, Sales Forecasts ($m), 2014–2020
Table 4: Zicronapine, Schizophrenia, The US, Sales Forecasts ($m), 2016–2020
Table 5: Zicronapine, Schizophrenia, UK, Sales Forecasts ($m), 2014–2020
Table 6: Zicronapine, Schizophrenia, France, Sales Forecasts ($m), 2014–2020
Table 7: Zicronapine, Schizophrenia, Germany, Sales Forecasts ($m), 2014–2020
Table 8: Zicronapine, Schizophrenia, Italy, Sales Forecasts ($m), 2014–2020
Table 9: Zicronapine, Schizophrenia, Spain, Sales Forecasts ($m), 2014–2020
1.2 List of Figures
Figure 1: Risk of Developing Schizophrenia
Figure 2: Environmental Factors in the Development of Schizophrenia
Figure 3: Schizophrenia, Global, Market Size Forecasts ($ billion), 2010–2020
Figure 4: Classification of Schizophrenia based on the Age of Disease Onset
Figure 5: Drug Model Diagram of Zicronapine
Figure 6: Zicronapine, Schizophrenia, Global, Sales Forecasts ($m), 2014–2020
Figure 7: Zicronapine, Schizophrenia, The US, Sales Forecasts ($m), 2016–2020
Figure 8: Zicronapine, Schizophrenia, UK, Sales Forecasts ($m), 2014–2020
Figure 9: Zicronapine, Schizophrenia, France, Sales Forecasts ($m), 2014–2020
Figure 10: Zicronapine, Schizophrenia, Germany, Sales Forecasts ($m), 2014–2020
Figure 11: Zicronapine, Schizophrenia, Italy, Sales Forecasts ($m), 2014–2020
Figure 12: Zicronapine, Schizophrenia, Spain, Sales Forecasts ($m), 2014–2020
Figure 13: Zicronapine, Schizophrenia, Global, Sales Distribution by Country (%), 2020
Ordering:
Order Online - http://www.researchandmarkets.com/reports/1934499/
Order by Fax - using the form below
Order by Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from
USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit
http://www.researchandmarkets.com/contact/
Order Information
Please verify that the product information is correct and select the format(s) you require.
Product Name:
Zicronapine - Analysis and Forecasts from 2014 to 2020
Web Address:
http://www.researchandmarkets.com/reports/1934499/
Office Code:
SCHL3FA7
Product Formats
Please select the product formats and quantity you require:
Quantity
Electronic (PDF) Site License:
USD 4000
Electronic (PDF) Single User:
USD 2000
Electronic (PDF) Enterprisewide:
USD 6000
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title:
First Name:
Mr
Mrs
Dr
Miss
Last Name:
Email Address: *
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
* Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)
Ms
Prof
Page 2 of 2
Payment Information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by credit card:
You will receive an email with a link to a secure webpage to enter your
credit card details.
Pay by check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Center,
Taylors Lane,
Dublin 8,
Ireland.
Pay by wire transfer:
Please transfer funds to:
Account number
833 130 83
Sort code
98-53-30
Swift code
ULSBIE2D
IBAN number
IE78ULSB98533083313083
Bank Address
Ulster Bank,
27-35 Main Street,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at
http://www.researchandmarkets.com/info/terms.asp
Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353-1-481-1716 or +353-1-653-1571 - From Rest of World